Table S1. Clinical outcome as a function of FBXO11 expression in breast cancer subtypes and Figure S1. FBXO11 facilitates protein degradation in a subclone-dependent manner. (PDF 315 kb
Table: HOXC11 KD downregulated genes. HOXC11 differentially expressed genes (DEGs) downregulated af...
Additional file 1: Table S1. Clinical pathological features of the selected 100 non-small cell lung ...
Figure S3. FTO-mediated m6A modification promoted stability of BNIP3 mRNA in an YTHDF2-independent m...
Figure S1. Gene expression in breast cancer. a Volcano plot of gene expression changes in the transc...
Figure S2. Expression of CPT1A lower in ER-negative, relative to ER-positive breast cancer cell line...
Figure S4. Immunohistochemistry (IHC) of 36 primary human breast tumors FFPE with specific antibodie...
Movie S1. Showing the development of MitoSOX red fluorescence in DMSO-treated MCF-7 cells. (AVI 9250...
Table S2. Differentially expressed genes in FTO-knockdown MDA-MB-231 cells. (XLSX 764 kb
Table: HOXC11 KD upregulated genes. HOXC11 differentially expressed genes (DEGs) upregulated after ...
Movie S2. Showing the development of MitoSOX red fluorescence in 1,25(OH)2D3-treated MCF-7 cells. (A...
Figure S5. Stable BNIP3-knockdown in FTO-knockdown MDA-MB-231 cells (a), MCF-7 cells (b) and 4âT1 ...
Figure S2. Stable knockdown of FTO in breast cancer cells by lentiviral shRNA sequences (shFTO#1 and...
NFI-C2 and FoxF1 regulates expression of genes involved in EMT. Reverse transcription PCR analysis o...
The graphs show the proliferation rate (BrdU; in % of control cells) for the seven different breast ...
Functional SNPs selected for the study. Table S2. Restriction fragment analysis for BRCA1 mutations....
Table: HOXC11 KD downregulated genes. HOXC11 differentially expressed genes (DEGs) downregulated af...
Additional file 1: Table S1. Clinical pathological features of the selected 100 non-small cell lung ...
Figure S3. FTO-mediated m6A modification promoted stability of BNIP3 mRNA in an YTHDF2-independent m...
Figure S1. Gene expression in breast cancer. a Volcano plot of gene expression changes in the transc...
Figure S2. Expression of CPT1A lower in ER-negative, relative to ER-positive breast cancer cell line...
Figure S4. Immunohistochemistry (IHC) of 36 primary human breast tumors FFPE with specific antibodie...
Movie S1. Showing the development of MitoSOX red fluorescence in DMSO-treated MCF-7 cells. (AVI 9250...
Table S2. Differentially expressed genes in FTO-knockdown MDA-MB-231 cells. (XLSX 764 kb
Table: HOXC11 KD upregulated genes. HOXC11 differentially expressed genes (DEGs) upregulated after ...
Movie S2. Showing the development of MitoSOX red fluorescence in 1,25(OH)2D3-treated MCF-7 cells. (A...
Figure S5. Stable BNIP3-knockdown in FTO-knockdown MDA-MB-231 cells (a), MCF-7 cells (b) and 4âT1 ...
Figure S2. Stable knockdown of FTO in breast cancer cells by lentiviral shRNA sequences (shFTO#1 and...
NFI-C2 and FoxF1 regulates expression of genes involved in EMT. Reverse transcription PCR analysis o...
The graphs show the proliferation rate (BrdU; in % of control cells) for the seven different breast ...
Functional SNPs selected for the study. Table S2. Restriction fragment analysis for BRCA1 mutations....
Table: HOXC11 KD downregulated genes. HOXC11 differentially expressed genes (DEGs) downregulated af...
Additional file 1: Table S1. Clinical pathological features of the selected 100 non-small cell lung ...
Figure S3. FTO-mediated m6A modification promoted stability of BNIP3 mRNA in an YTHDF2-independent m...